# Filing Detail

Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0000950170-22-023982
Filing Date
2022-11-09
Accepted
2022-11-09 17:13:55
Documents
63
Period of Report
2022-09-30

Document Format Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
1 | 10-Q | tern-20220930.htm iXBRL | 10-Q | 3160163
2 | EX-10.1(A) | tern-ex10_1a.htm | EX-10.1(A) | 249018
3 | EX-10.1(B) | tern-ex10_1b.htm | EX-10.1(B) | 188582
4 | EX-10.1(C) | tern-ex10_1c.htm | EX-10.1(C) | 155533
5 | EX-31.1 | tern-ex31_1.htm | EX-31.1 | 20597
6 | EX-31.2 | tern-ex31_2.htm | EX-31.2 | 20598
7 | EX-32.1 | tern-ex32_1.htm | EX-32.1 | 12458
8 | EX-32.2 | tern-ex32_2.htm | EX-32.2 | 12465
9 | GRAPHIC | img254958980_0.jpg | GRAPHIC | 33416
10 | GRAPHIC | img254958980_1.jpg | GRAPHIC | 29267
| Complete submission text file | 0000950170-22-023982.txt |  | 11997528

Data Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
11 | XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT | tern-20220930.xsd | EX-101.SCH | 63435
12 | XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT | tern-20220930_lab.xml | EX-101.LAB | 530566
13 | XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT | tern-20220930_def.xml | EX-101.DEF | 234740
14 | XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT | tern-20220930_pre.xml | EX-101.PRE | 387223
15 | XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT | tern-20220930_cal.xml | EX-101.CAL | 54437
57 | EXTRACTED XBRL INSTANCE DOCUMENT | tern-20220930_htm.xml | XML | 2371948

Mailing Address 1065 EAST HILLSDALE BLVD., SUITE 100 FOSTER CITY CA 94404
Business Address 1065 EAST HILLSDALE BLVD., SUITE 100 FOSTER CITY CA 94404 650-525-5535 EXT.101
Terns Pharmaceuticals, Inc. (Filer) CIK: 0001831363 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-39926 | Film No.: 221373669
SIC: 2834 Pharmaceutical Preparations